By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Clinical-stage biotherapeutic company developing novel therapeutics for diseases with large unmet58K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States58K100.00%